Restore Vision has conducted the first comprehensive review of FDA-approved excipients in ophthalmic medications, examining their roles, safety, and the regulatory pathways required for approval for human use.
Month: January 2025
Restore Vision’s first review meeting
On January, 30. The RESTORE VISION team held its first review meeting to assess project progress and discuss plans for the upcoming year.